HSBC Holdings’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $36.5M | Buy |
379,586
+103,392
| +37% | +$10.6M | 0.02% | 596 |
|
|
2025
Q4 | $29.6M | Buy |
276,194
+222,327
| +413% | +$25.8M | 0.02% | 633 |
|
|
2025
Q3 | $6.83M | Buy |
53,867
+40,153
| +293% | +$4.78M | ﹤0.01% | 1068 |
|
|
2025
Q2 | $1.68M | Sell |
13,714
-63,521
| -82% | -$7.25M | ﹤0.01% | 1554 |
|
|
2025
Q1 | $7.78M | Buy |
77,235
+35,513
| +85% | +$3.47M | ﹤0.01% | 971 |
|
|
2024
Q4 | $3.86M | Buy |
41,722
+7,061
| +20% | +$693K | ﹤0.01% | 1227 |
|
|
2024
Q3 | $3.33M | Sell |
34,661
-34,314
| -50% | -$3.08M | ﹤0.01% | 1254 |
|
|
2024
Q2 | $5.92M | Sell |
68,975
-3,153
| -4% | -$265K | ﹤0.01% | 1008 |
|
|
2024
Q1 | $5.96M | Sell |
72,128
-6,191
| -8% | -$453K | ﹤0.01% | 1036 |
|
|
2023
Q4 | $5.21M | Buy |
78,319
+15,644
| +25% | +$1.01M | ﹤0.01% | 1130 |
|
|
2023
Q3 | $4.21M | Buy |
62,675
+58,410
| +1,370% | +$4.02M | ﹤0.01% | 1149 |
|
|
2023
Q2 | $289K | Sell |
4,265
-66,954
| -94% | -$4.2M | ﹤0.01% | 2167 |
|
|
2023
Q1 | $3.82M | Buy |
71,219
+67,044
| +1,606% | +$3.9M | ﹤0.01% | 1228 |
|
|
2022
Q4 | $250K | Buy |
+4,175
| New | +$227K | ﹤0.01% | 2663 |
|
|
2022
Q2 | – | Sell |
-7,836
| Closed | -$443K | – | 3293 |
|
|
2022
Q1 | $443K | Sell |
7,836
-46,901
| -86% | -$2.45M | ﹤0.01% | 2511 |
|
|
2021
Q4 | $2.86M | Buy |
54,737
+22,971
| +72% | +$1.19M | ﹤0.01% | 1521 |
|
|
2021
Q3 | $1.91M | Sell |
31,766
-8,243
| -21% | -$519K | ﹤0.01% | 1550 |
|
|
2021
Q2 | $2.46M | Buy |
40,009
+27,954
| +232% | +$1.86M | ﹤0.01% | 1358 |
|
|
2021
Q1 | $790K | Buy |
12,055
+5,351
| +80% | +$349K | ﹤0.01% | 1721 |
|
|
2020
Q4 | $440K | Sell |
6,704
-3,693
| -36% | -$217K | ﹤0.01% | 2284 |
|
|
2020
Q3 | $536K | Sell |
10,397
-20,433
| -66% | -$1.05M | ﹤0.01% | 1886 |
|
|
2020
Q2 | $1.52M | Buy |
30,830
+16,215
| +111% | +$875K | ﹤0.01% | 1271 |
|
|
2020
Q1 | $741K | Sell |
14,615
-2,986
| -17% | -$172K | ﹤0.01% | 1591 |
|
|
2019
Q4 | $960K | Sell |
17,601
-12,704
| -42% | -$689K | ﹤0.01% | 1856 |
|
|
2019
Q3 | $1.53M | Sell |
30,305
-122,766
| -80% | -$6.17M | ﹤0.01% | 1738 |
|
|
2019
Q2 | $7.72M | Sell |
153,071
-58,179
| -28% | -$2.82M | 0.01% | 949 |
|
|
2019
Q1 | $9.81M | Sell |
211,250
-56,507
| -21% | -$2.86M | 0.02% | 817 |
|
|
2018
Q4 | $13.1M | Sell |
267,757
-18,168
| -6% | -$1.03M | 0.02% | 678 |
|
|
2018
Q3 | $17.7M | Buy |
285,925
+280,512
| +5,182% | +$17.1M | 0.03% | 601 |
|
|
2018
Q2 | $292K | Sell |
5,413
-22,233
| -80% | -$1.11M | ﹤0.01% | 2290 |
|
|
2018
Q1 | $1.26M | Buy |
27,646
+9,442
| +52% | +$405K | ﹤0.01% | 1558 |
|
|
2017
Q4 | $716K | Buy |
18,204
+3,085
| +20% | +$117K | ﹤0.01% | 1401 |
|
|
2017
Q3 | $557K | Buy |
15,119
+1,899
| +14% | +$67.7K | ﹤0.01% | 1687 |
|
|
2017
Q2 | $509K | Sell |
13,220
-362
| -3% | -$13.3K | ﹤0.01% | 1691 |
|
|
2017
Q1 | $462K | Sell |
13,582
-17,838
| -57% | -$586K | ﹤0.01% | 1634 |
|
|
2016
Q4 | $1.03M | Buy |
31,420
+18,453
| +142% | +$599K | ﹤0.01% | 1409 |
|
|
2016
Q3 | $419K | Hold |
12,967
| – | – | ﹤0.01% | 1622 |
|
|
2016
Q2 | $400K | Sell |
12,967
-91
| -0.7% | -$2.85K | ﹤0.01% | 1650 |
|
|
2016
Q1 | $391K | Buy |
13,058
+477
| +4% | +$13.2K | ﹤0.01% | 1639 |
|
|
2015
Q4 | $349K | Buy |
12,581
+2,094
| +20% | +$59.6K | ﹤0.01% | 1810 |
|
|
2015
Q3 | $320K | Buy |
10,487
+1,010
| +11% | +$35.2K | ﹤0.01% | 1582 |
|
|
2015
Q2 | $347K | Sell |
9,477
-18
| -0.2% | -$642 | ﹤0.01% | 1545 |
|
|
2015
Q1 | $335K | Buy |
+9,495
| New | +$325K | ﹤0.01% | 1704 |
|
Other funds holding EHC
VPM
VCM
HSBC Holdings's EHC Position: Q1 2026 in Review
HSBC Holdings increased its Encompass Health (EHC) stake by 37% in Q1 2026, buying an estimated $10.6M and bringing the position to 379,586 shares worth $36.5M. The position accounts for 0.02% of the portfolio, ranked #596.
HSBC Holdings first reported a position in EHC in Q1 2015 and has held it in 43 quarters since. 578 funds tracked by Wall St. Rank hold EHC as of Q1 2026.
- HSBC Holdings held 379,586 shares of Encompass Health worth $36.5M as of Q1 2026.
- HSBC Holdings bought 103,392 Encompass Health shares in Q1 2026, an estimated $10.6M.
- Encompass Health made up 0.02% of HSBC Holdings's portfolio in Q1 2026, its #596 holding.
- HSBC Holdings first reported a position in Encompass Health in Q1 2015 and has held it in 43 quarters since.
- 578 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.